Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Intensive Care Medicine

Navigating the Neuro-ICU: The Critical Two-Week Window

At a Glance

The 14 days after an aneurysmal subarachnoid hemorrhage (aSAH) are critical for preventing secondary brain injury. Neuro-ICU teams use medications like nimodipine, TCD ultrasounds, and frequent neurologic checks to detect and treat dangerous complications like vasospasm and hydrocephalus early.

Securing the aneurysm is a major milestone, but it is only the first step in the journey through the Neuro-Intensive Care Unit (NICU). The next 14 days are a critical period where the focus shifts from the aneurysm itself to protecting the brain from secondary injuries.

In the NICU, you may hear doctors and nurses talking about the “high-risk window” between days 3 and 14 after the bleed [1]. This is when the brain is most vulnerable to specific complications.

Understanding Vasospasm and DCI

One of the most significant challenges after an aSAH is vasospasm. This happens when the blood that leaked out during the hemorrhage irritates the nearby arteries, causing them to narrow or “spasm” [2].

If these arteries narrow too much, they can restrict blood flow and oxygen to parts of the brain. This can lead to Delayed Cerebral Ischemia (DCI), a condition where the brain doesn’t get enough oxygen, potentially causing a secondary stroke [1][3]. Because this happens several days after the initial event, the medical team performs frequent neurological checks to catch even subtle changes in alertness or strength.

Monitoring and Prevention

To stay ahead of these risks, the NICU team uses several tools and treatments:

1. Oral Nimodipine: The Standard of Care

Nimodipine is a medication that everyone with an aSAH receives for about 21 days [4][5]. It is the only FDA-approved drug proven to improve outcomes and prevent neurological deficits by protecting brain cells and potentially reducing the effects of vasospasm [4][6].

  • Note: The most common side effect is low blood pressure (hypotension), so the team monitors your vitals closely and may adjust the dose if needed [5].

2. Transcranial Doppler (TCD) Ultrasounds

TCDs are bedside tests that use sound waves to measure the speed of blood flowing through the brain’s arteries [7][8]. This test is completely painless; a technician simply places ultrasound gel and a small wand on the side of your head [7].

  • Faster flow usually indicates that an artery is narrowing (like putting your thumb over a garden hose) [9].
  • The team looks for a Lindegaard ratio—a comparison of blood speed in different vessels—to help tell the difference between a natural increase in blood flow and a true vasospasm [9].

3. Anti-Seizure Medications

It is extremely common for the care team to prescribe anti-seizure medications (such as levetiracetam, often known as Keppra) as a preventative measure [10]. Do not panic if you see “epilepsy drugs” on your chart; they are used temporarily to protect the irritated brain from seizing [10].

Managing Pressure: Hydrocephalus and Drains

Blood from the initial hemorrhage can block the brain’s natural drainage system, leading to a buildup of cerebrospinal fluid (CSF). This condition is called hydrocephalus, and it can increase pressure inside the skull [11][12].

To manage this pressure, doctors may use specialized drains:

  • External Ventricular Drain (EVD): A small tube inserted through the skull into the fluid-filled chambers (ventricles) of the brain. It allows excess fluid to drain into a bag at the bedside, immediately relieving pressure [13][14].
  • Lumbar Drain: A similar tube placed in the lower back (the lumbar space) to drain fluid from the spinal column [15].

The team will eventually try to “wean” or “challenge” these drains by closing them for short periods to see if the brain can resume its own fluid drainage [13]. If it cannot, some patients may eventually need a permanent internal drain called a shunt [16].

Why the ICU is So Busy

If you feel like you are being woken up every hour for checks, it is for a vital reason. The “3-to-14-day window” is when the team is on high alert for DCI [1]. Early detection of a slight change in your ability to follow commands or move your limbs allows the team to intervene quickly—sometimes with IV fluids or specialized procedures—to restore blood flow and protect your recovery [17][18]. Learn what happens after leaving the hospital in Life After aSAH.

Common questions in this guide

Why is the 14-day window in the Neuro-ICU so critical after an aSAH?
The 14 days following an aneurysmal subarachnoid hemorrhage are a high-risk period for secondary complications. During this time, the brain is especially vulnerable to conditions like vasospasm and delayed cerebral ischemia, requiring intensive, around-the-clock monitoring.
What is a vasospasm and why does it happen?
A vasospasm occurs when blood from the initial hemorrhage irritates nearby brain arteries, causing them to narrow. If the arteries narrow too much, it can restrict blood flow and oxygen to the brain, potentially causing a secondary stroke known as delayed cerebral ischemia.
Why am I being prescribed nimodipine?
Nimodipine is a standard, FDA-approved medication typically given for about 21 days after an aSAH. It helps protect brain cells, may reduce the harmful effects of vasospasm, and has been proven to improve overall neurological outcomes.
What does a Transcranial Doppler (TCD) ultrasound do?
A TCD is a painless bedside test that uses sound waves to measure how fast blood is flowing through your brain's arteries. Faster blood flow usually signals that an artery is narrowing, allowing the medical team to detect vasospasms before they cause lasting damage.
Why might an external ventricular drain (EVD) be needed?
Blood from the hemorrhage can block the brain's natural fluid drainage, causing cerebrospinal fluid to build up and increase pressure inside the skull. An EVD is a small tube placed in the brain to safely drain this excess fluid and immediately relieve the pressure.
Why are epilepsy or anti-seizure drugs on my medication list?
Anti-seizure medications, such as levetiracetam (Keppra), are very commonly prescribed as a temporary preventative measure. They are used to protect the irritated brain from seizing while it heals from the hemorrhage.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was the mean flow velocity on today’s TCD ultrasound, and how does it compare to yesterday’s?
  2. 2.Are there any signs of vasospasm or delayed cerebral ischemia (DCI) that we should be looking for at the bedside?
  3. 3.Is the patient tolerating the full dose of nimodipine, or has it been lowered because of blood pressure concerns?
  4. 4.If a drain is in place, what is the plan for 'weaning' it to see if they can drain spinal fluid on their own?
  5. 5.What is the risk of the patient needing a permanent shunt versus a temporary drain?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Radiographic Evaluation and Clinical Management of Cerebral Vasospasm.

    Amuluru K, Shah KJ, Payner TD, et al.

    Neuroimaging clinics of North America 2025; (35(3)):383-395 doi:10.1016/j.nic.2025.04.006.

    PMID: 40634006
  2. 2

    Predictive value of the transcranial Doppler and mean arterial flow velocity for early detection of cerebral vasospasm in aneurysmal subarachnoid hemorrhage.

    Esmael A, Flifel ME, Elmarakby F, Belal T

    Ultrasound (Leeds, England) 2021; (29(4)):218-228 doi:10.1177/1742271X20976965.

    PMID: 34777542
  3. 3

    Aneurysmal Subarachnoid Hemorrhage: Strategies for Preventing Vasospasm in the Intensive Care Unit.

    Diringer MN, Zazulia AR

    Seminars in respiratory and critical care medicine 2017; (38(6)):760-767 doi:10.1055/s-0037-1607990.

    PMID: 29262433
  4. 4

    An overview of pharmacotherapy for cerebral vasospasm and delayed cerebral ischemia after subarachnoid hemorrhage.

    Maruhashi T, Higashi Y

    Expert opinion on pharmacotherapy 2021; (22(12)):1601-1614 doi:10.1080/14656566.2021.1912013.

    PMID: 33823726
  5. 5

    Poor Utilization of Nimodipine in Aneurysmal Subarachnoid Hemorrhage.

    Hajizadeh Barfejani A, Rabinstein AA, Wijdicks EFM, Clark SL

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2019; (28(8)):2155-2158 doi:10.1016/j.jstrokecerebrovasdis.2019.04.024.

    PMID: 31103551
  6. 6

    Neuroinflammation as a Target for Intervention in Subarachnoid Hemorrhage.

    de Oliveira Manoel AL, Macdonald RL

    Frontiers in neurology 2018; (9()):292 doi:10.3389/fneur.2018.00292.

    PMID: 29770118
  7. 7

    The Role of Transcranial Doppler in Cerebral Vasospasm: A Literature Review.

    Sharma S, Lubrica RJ, Song M, et al.

    Acta neurochirurgica. Supplement 2020; (127()):201-205 doi:10.1007/978-3-030-04615-6_32.

    PMID: 31407086
  8. 8

    Diagnostic Ultrasonography in Neurology.

    Azevedo E

    Continuum (Minneapolis, Minn.) 2023; (29(1)):324-363 doi:10.1212/CON.0000000000001241.

    PMID: 36795882
  9. 9

    The TCD hyperemia index to detect vasospasm and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage.

    Kim Y, Mehta A, Nair R, et al.

    Journal of neuroimaging : official journal of the American Society of Neuroimaging 2023; (33(5)):725-730 doi:10.1111/jon.13132.

    PMID: 37291461
  10. 10

    Aneurysmal Subarachnoid Hemorrhage.

    Chung DY, Abdalkader M, Nguyen TN

    Neurologic clinics 2021; (39(2)):419-442 doi:10.1016/j.ncl.2021.02.006.

    PMID: 33896527
  11. 11

    Review of the Prevention and Treatment of Hydrocephalus After Aneurysmal Subarachnoid Hemorrhage.

    Yang C, Li Y

    World neurosurgery 2022; (168()):134-138 doi:10.1016/j.wneu.2022.08.089.

    PMID: 36041720
  12. 12

    Cerebrospinal fluid drainage and chronic hydrocephalus in aneurysmal subarachnoid hemorrhage patients with intraventricular hemorrhage.

    Wu B, Zhou Y, Fan H, et al.

    Frontiers in neurology 2023; (14()):1302622 doi:10.3389/fneur.2023.1302622.

    PMID: 38164202
  13. 13

    External Ventricular Drainage before Endovascular Treatment in Patients with Aneurysmal Subarachnoid Hemorrhage in Acute Period: Its Relation to Hemorrhagic Complications.

    Lim YC, Shim YS, Oh SY, et al.

    Neurointervention 2019; (14(1)):35-42 doi:10.5469/neuroint.2018.01067.

    PMID: 30636388
  14. 14

    Ventriculitis incidence and outcomes in patients with aneurysmal subarachnoid hemorrhage: a prospective observational study.

    Turon R, Kurtz P, Rynkowski C, et al.

    Critical care science 2025; (37()):e20250076 doi:10.62675/2965-2774.20250076.

    PMID: 39879431
  15. 15

    Different cerebrospinal fluid drainage methods and chronic hydrocephalus in patients with aneurysmal subarachnoid hemorrhage.

    Zhou Y, Liu Z, Yan H, et al.

    Frontiers in neurology 2025; (16()):1564927 doi:10.3389/fneur.2025.1564927.

    PMID: 40297855
  16. 16

    Volumetric quantification of aneurysmal subarachnoid hemorrhage independently predicts hydrocephalus and seizures.

    Daou BJ, Khalsa SSS, Anand SK, et al.

    Journal of neurosurgery 2021; (135(4)):1155-1163 doi:10.3171/2020.8.JNS201273.

    PMID: 33545677
  17. 17

    Construction and verification of risk predicting models to evaluate the possibility of hydrocephalus following aneurysmal subarachnoid hemorrhage.

    Hao G, Shi Z, Huan Y, et al.

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2024; (33(2)):107535 doi:10.1016/j.jstrokecerebrovasdis.2023.107535.

    PMID: 38134551
  18. 18

    Acute Multidisciplinary Management of Aneurysmal Subarachnoid Hemorrhage (aSAH).

    Ran KR, Wang AC, Nair SK, et al.

    Balkan medical journal 2023; (40(2)):74-81 doi:10.4274/balkanmedj.galenos.2023.2023-1-100.

    PMID: 36883719

This page provides educational information about Neuro-ICU care and monitoring following an aSAH. It is not a substitute for professional medical advice; always consult the intensive care team regarding specific treatments, medications, and clinical decisions.

Get notified when new evidence is published on Acquired aneurysmal subarachnoid hemorrhage.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.